cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Gelesis Holdingsinc
2 own
3 watching
Current Price
$0
$0.02
(6.67%)
logo-gls
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
21.9M
52-Week High
52-Week High
6.25
52-Week Low
52-Week Low
0.221
Average Volume
Average Volume
2.66M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization21.9M
icon52-Week High6.25
icon52-Week Low0.221
iconAverage Volume2.66M
iconDividend Yield--
iconP/E Ratio--
What does the Gelesis Holdingsinc do?
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Read More
News & Events about Gelesis Holdingsinc.
Business Wire
5 months ago
Gelesis Holdings Inc. (NYSE: GLS) (Gelesis or the Company) the maker of Plenity for weight management, today announced that the Company is participating in a fireside chat with IPO Edge today at 2:00 PM ET. The fireside chat will be hosted by Yishai Zohar, Founder and Chief Executive Officer...
Business Wire
8 months ago
Gelesis (NYSE: GLS), the maker of Plenity for weight management, presented new findings about the role of language in obesity and diabetes scientific literature at the American Diabetes Associations annual conference. The study sought to understand the extent to which person-first language, or...
Business Wire
8 months ago
Gelesis (NYSE: GLS), the maker of Plenity for weight management, presented new preclinical data showing weight loss and additional metabolic benefits in mice receiving a microbiota transplant from another group of mice, treated with one of the companys proprietary hydrogels. These metabolic...
Benzinga
10 months ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Gelesis Holdingsinc share price today?
plus_minus_icon
Can Indians buy Gelesis Holdingsinc shares?
plus_minus_icon
How can I buy Gelesis Holdingsinc shares from India?
plus_minus_icon
Can Fractional shares of Gelesis Holdingsinc be purchased?
plus_minus_icon
What are the documents required to start investing in Gelesis Holdingsinc stocks?
plus_minus_icon
What is today’s traded volume of Gelesis Holdingsinc?
plus_minus_icon
What is today’s market capitalisation of Gelesis Holdingsinc?
plus_minus_icon
What is the 52-Week High and Low Range of Gelesis Holdingsinc?
plus_minus_icon
What percentage is Gelesis Holdingsinc down from its 52-Week High?
plus_minus_icon
What percentage is Gelesis Holdingsinc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.02
(6.67%)
logo-gls
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00